A carregar...
MET inhibitors for treatment of advanced hepatocellular carcinoma: A review
The current standard treatment option for advanced hepatocellular carcinoma (HCC) is sorafenib, but its clinical benefit is modest. In spite of many attempts, few drugs can provide any significant improvement of survival as the first- or second-line therapy of choice in phase III randomized controll...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4427665/ https://ncbi.nlm.nih.gov/pubmed/25987766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i18.5445 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|